Here are four notes:
1. The company has the high P/E ratio on Wall Street at 98.50. The P/E ratio is equal to a stock’s market capitalization divided by its after-tax earnings over a 12-month period.
2. The stock, currently at $99.49, is up 12.08 percent from its 52-week low.
3. The stock trades at an average volume of 1.18 million shares.
4. Zimmer Biomet’s key competitors include ConforMIS, LDR Holding and Globus Medical.
More articles on devices:
Grab some rays — Active individuals may need to maintain higher vitamin D levels to minimize stress fracture risk
Houston Methodis Hospital implements CT-free robotic surgery — 5 key points
OrthoSensor raises $3.9M in funding: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
